CN102918050B - 肠顶端膜钠/磷协同转运的芳基氟磷酸酯抑制剂 - Google Patents

肠顶端膜钠/磷协同转运的芳基氟磷酸酯抑制剂 Download PDF

Info

Publication number
CN102918050B
CN102918050B CN201180021463.0A CN201180021463A CN102918050B CN 102918050 B CN102918050 B CN 102918050B CN 201180021463 A CN201180021463 A CN 201180021463A CN 102918050 B CN102918050 B CN 102918050B
Authority
CN
China
Prior art keywords
compound
formula
pharmaceutically acceptable
acceptable salt
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201180021463.0A
Other languages
English (en)
Chinese (zh)
Other versions
CN102918050A (zh
Inventor
布莱恩·皮尔斯
拉里·斯洛莫维茨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DUOPHOS
Original Assignee
DUOPHOS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DUOPHOS filed Critical DUOPHOS
Publication of CN102918050A publication Critical patent/CN102918050A/zh
Application granted granted Critical
Publication of CN102918050B publication Critical patent/CN102918050B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/141Esters of phosphorous acids
    • C07F9/146Esters of phosphorous acids containing P-halide groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/14Esters of phosphoric acids containing P(=O)-halide groups
    • C07F9/1406Esters of phosphoric acids containing P(=O)-halide groups containing the structure Hal-P(=O)-O-aryl

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201180021463.0A 2010-03-05 2011-03-04 肠顶端膜钠/磷协同转运的芳基氟磷酸酯抑制剂 Expired - Fee Related CN102918050B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31090210P 2010-03-05 2010-03-05
US61/310,902 2010-03-05
PCT/US2011/027232 WO2011109731A2 (en) 2010-03-05 2011-03-04 Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport

Publications (2)

Publication Number Publication Date
CN102918050A CN102918050A (zh) 2013-02-06
CN102918050B true CN102918050B (zh) 2015-07-01

Family

ID=44542860

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201180021463.0A Expired - Fee Related CN102918050B (zh) 2010-03-05 2011-03-04 肠顶端膜钠/磷协同转运的芳基氟磷酸酯抑制剂

Country Status (13)

Country Link
US (2) US8921343B2 (https=)
EP (1) EP2542560B8 (https=)
JP (1) JP5819865B2 (https=)
CN (1) CN102918050B (https=)
AU (1) AU2011222551B2 (https=)
BR (1) BR112012022349B1 (https=)
CA (1) CA2792093C (https=)
ES (1) ES2561672T3 (https=)
IL (1) IL221747A (https=)
MX (1) MX2012010288A (https=)
NZ (1) NZ602703A (https=)
RU (1) RU2566757C2 (https=)
WO (1) WO2011109731A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011222551B2 (en) * 2010-03-05 2016-10-06 Duophos Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport
WO2017111087A1 (ja) * 2015-12-25 2017-06-29 ステラケミファ株式会社 モノフルオロリン酸エステル塩、その製造方法及びフッ素イオン放出性組成物
CN119431437B (zh) * 2024-11-04 2025-09-30 山东花物堂生物科技有限公司 丹皮酚磷酸酯及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2371910A1 (en) * 1999-01-21 2000-07-27 Brian E. Peerce Inhibitors of intestinal apical membrane na/phosphate co-transportation
US7119120B2 (en) * 2001-12-26 2006-10-10 Genzyme Corporation Phosphate transport inhibitors
ATE337326T1 (de) * 2002-03-19 2006-09-15 Genzyme Corp Hemmer des phosphattransports
RU2279676C2 (ru) * 2003-06-16 2006-07-10 Уральская государственная академия ветеринарной медицины Способ контроля над репаративным остеогенезом у животных
ES2633689T3 (es) * 2009-01-26 2017-09-22 Opko Ireland Global Holdings, Limited Regulación de fosfato con moléculas pequeñas
AU2011222551B2 (en) * 2010-03-05 2016-10-06 Duophos Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BRIAN E. PEERCE,et al..A phosphorylated phloretin derivative. Synthesis and effect on intestinal Na+-dependent phosphate absorption.《Am J Physiol Gastrointest Liver Physiol》.2001,第283卷G848-G855. *
Fluorinated organophosphates for biomedical targets;Vadim D. Romanenko, et al.;《Tetrahedron》;20080422;第64卷;6153-6190 *

Also Published As

Publication number Publication date
US20130059822A1 (en) 2013-03-07
EP2542560A4 (en) 2014-10-15
HK1180692A1 (zh) 2013-10-25
AU2011222551A1 (en) 2012-09-27
BR112012022349A2 (pt) 2016-07-05
EP2542560B8 (en) 2015-12-30
NZ602703A (en) 2015-01-30
WO2011109731A2 (en) 2011-09-09
US8921343B2 (en) 2014-12-30
MX2012010288A (es) 2013-02-27
AU2011222551B2 (en) 2016-10-06
BR112012022349B1 (pt) 2019-09-24
CA2792093C (en) 2018-05-22
US9328128B2 (en) 2016-05-03
US20150080597A1 (en) 2015-03-19
ES2561672T8 (es) 2016-03-11
RU2012142336A (ru) 2014-04-10
JP5819865B2 (ja) 2015-11-24
EP2542560A2 (en) 2013-01-09
CN102918050A (zh) 2013-02-06
CA2792093A1 (en) 2011-09-09
IL221747A (en) 2016-02-29
ES2561672T3 (es) 2016-02-29
JP2013521337A (ja) 2013-06-10
RU2566757C2 (ru) 2015-10-27
WO2011109731A3 (en) 2012-03-01
EP2542560B1 (en) 2015-11-11

Similar Documents

Publication Publication Date Title
IL211429A (en) HISTORY 1 - Naphthalene triazole and a pharmaceutical composition containing them
TW201028142A (en) Heterobicyclic sphingosine 1-phosphate analogs
JP2023182589A (ja) フェニルスルホンアミドを含む薬学的組成物、及びそれらの治療的適用
JP2021523934A (ja) ミトコンドリア脱共役剤として有用なアミノピラジンおよび関連化合物
CN102918050B (zh) 肠顶端膜钠/磷协同转运的芳基氟磷酸酯抑制剂
JP2018504411A (ja) 感覚有毛細胞の死を防ぐまたは処置するための化合物と方法
US11434198B2 (en) Compounds and methods for the treatment of neurodegenerative diseases
JPH10500977A (ja) ピリジルビスホスホン酸エステルよりなる治療用活性薬剤
US20180118661A1 (en) Compounds and methods for the treatment of neurodegenerative diseases
JP5747263B2 (ja) 神経細胞死抑制剤
TW202412813A (zh) 含硒元素的查爾酮化合物及其製備方法、包含其的醫藥組合物、以及用於製備預防或治療大腸癌之醫藥組合物的用途
EP2389183B1 (en) Phosphate management with small molecules
HK1180692B (en) Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport
CN109293681B (zh) 一种抗结核化合物及其在制备抗结核药物中的应用以及一种抗结核药物组合物
WO2020028552A1 (en) Methods of activating microglial cells
EP0308349A1 (fr) Nouveau derivé de choline, son procédé de préparation et nouveaux médicaments le contenant
HK1164697A (en) Phosphate management with small molecules
HK1164697B (en) Phosphate management with small molecules

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150701

CF01 Termination of patent right due to non-payment of annual fee